DrugPatentWatch Database Preview
Drugs in Development Information for Gliolan
» See Plans and Pricing
What is the development status for investigational drug Gliolan?
Gliolan is an investigational drug.
There have been 15 clinical trials for Gliolan.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2010.
The most common disease conditions in clinical trials are Glioblastoma, Glioma, and Brain Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), University Hospital, Lille, and Institut National de la Santé Et de la Recherche Médicale, France.
There are one hundred and eight US patents protecting this investigational drug and seven hundred and sixty-one international patents.
Summary for Gliolan
| US Patents | 108 |
| International Patents | 761 |
| US Patent Applications | 174 |
| WIPO Patent Applications | 84 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 3 (2010-11-01) |
| Vendors | 95 |
Recent Clinical Trials for Gliolan
| Title | Sponsor | Phase |
|---|---|---|
| Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma | Institut National de la Santé Et de la Recherche Médicale, France | Phase 2 |
| Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma | University Hospital, Lille | Phase 2 |
| Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma | Deutsche Krebshilfe e.V., Bonn (Germany) | Phase 2 |
Clinical Trial Summary for Gliolan
Top disease conditions for Gliolan
Top clinical trial sponsors for Gliolan
US Patents for Gliolan
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Gliolan | Start Trial | Method for the treatment of acne | DUSA PHARMACEUTICALS, INC. (Wilmington, MA) | Start Trial |
| Gliolan | Start Trial | Multispectral wide-field endoscopic imaging of fluorescence | University of Washington (Seattle, WA) | Start Trial |
| Gliolan | Start Trial | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | Start Trial |
| Gliolan | Start Trial | Theranostics platform and methods of use | Sanford Burnham Prebys Medical Discovery (La Jolla, CA) | Start Trial |
| Gliolan | Start Trial | Genetically modified microorganism for producing medium-chain lauric acid and/or dodecanedioic acid and method of using thereof | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (Hsinchu, TW) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Gliolan
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Gliolan | Australia | 2013299487 | 2032-08-10 | Start Trial |
| Gliolan | Canada | 2881439 | 2032-08-10 | Start Trial |
| Gliolan | European Patent Office | 2882432 | 2032-08-10 | Start Trial |
| Gliolan | World Intellectual Property Organization (WIPO) | 2014026077 | 2032-08-10 | Start Trial |
| Gliolan | Australia | 2017261372 | 2036-05-05 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
